Stephen Hayden, MD

Stephen Hayden, MD, received his medical degree (MB,BS) from the University of London in 1968 and an advanced medical degree (MD) from the University of Birmingham, England, in 1982.

He completed training in both general internal medicine and pulmonary diseases in Southend, the London Hospital and Birmingham. He was involved in research in asthma at the London Hospital, and the effects of welding fume at the University of Birmingham School of Medicine.

He joined the staff of Cleveland Clinic in 1980. He has been the Quality Improvement Officer for the Department of General Internal Medicine for many years.

Dr. Hayden currently sees patients in consultation, or as a second opinion visit, for diagnosis and coordination of care; most of the patients have multiple medical conditions.

His additional interests and activities involve quality management and improvement, and the application of information technology to clinical systems, quality and patient safety.

Education & Professional Highlights

Appointed
1980

Education & Fellowships

Medical School - The London Hospital
Research Fellowship
London,
1974

Fellowship - Queen Elizabeth Medical Centre
Birmingham,
1974

Residency - Southend Group of Hospitals, England
General Medicine
Southend,
1972

Medical School - The London Hospital Medical College, Univ. of London Faculty of Med, England
London,
1968

Additional Training

Pulmonary Medicine, Birmingham UK
Quality Improvement Methods, Institute for Healthcare Improvement

Certifications

Internal Medicine

Specialty Interests

Chronic disease management, Diagnostic internal medicine, Medical information systems, Pulmonary Embolism, Quality improvement and patient safety methods

Awards & Honors

America's Best Doctors, 2011 and previously

Research & Publications

See publications for Stephen Hayden, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/2/2018, Dr. Hayden has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Cleveland Clinic Menu

Primary Location

Cleveland Clinic Main Campus

Treatment & Services

Specialty in Diseases & Conditions

Insurance

Is Cleveland Clinic Florida Part of Your Insurance?

About Stephen Hayden, MD